← Human Trials & Peer-Reviewed Studies
Correlation analysis of IGF-1, ZAG, nesfatin-1, HbA1c levels, and type 2 diabetes mellitus complicated with hypothyroidism
Plain-language guide to PMID 33847643 (2021): observational study of IGF-1 LR3 in 55 patients.
Key Facts
- PMID
- 33847643
- Journal
- Medicine
- Year
- 2021
- Study type
- Observational Study
- Authors
- He S et al. (4 authors)
- DOI
- 10.1097/MD.0000000000025432
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of IGF-1 LR3, published as an observational study.
To analyze the correlation between IGF-1, ZAG, nesfatin-1, HbA1c levels, and type 2 diabetes mellitus (T2DM) complicated with hypothyroidism.Fifty-five patients with type-2 diabetes who were admitted to their hospital from August 2018 to February 2020 were selected as the control group, and 55 patients with type 2 diabetes combined with hypothyroidism who were admitted to the hospital at the same period were selected as the combined group, and 56 patients who came to their hospital for physical examination at the same period were selected as the healthy group.
The general clinical data and relevant laboratory indexes of all patients in the three groups were collected and statistically analyzed.
Who Took Part
According to the abstract, 55 patients were involved.
By PubMed's age tags, the people studied were adults and middle-aged adults, both men and women.
What Was Measured
To analyze the correlation between IGF-1, ZAG, nesfatin-1, HbA1c levels, and type 2 diabetes mellitus (T2DM) complicated with hypothyroidism.Fifty-five patients with type-2 diabetes who were admitted to their hospital from August 2018 to February 2020 were selected as the control group, and 55 patients with type 2 diabetes combined with hypothyroidism who were admitted to the hospital at the same period were selected as the combined group, and 56 patients who came to their hospital for physical examination at the same period were selected as the healthy group.
The subject headings attached to it are Age Factors, Blood Glucose, Body Mass Index, Comorbidity, Diabetes Mellitus, Type 2, Glycated Hemoglobin and Health Behavior.
What This Means in Plain Language
This is an observational study of IGF-1 LR3 in 55 patients.
The publication is from 2021 (Medicine), a journal based in United States.
More context: the IGF-1 LR3 compound page, all human trials.
Our Notes on the Compound
IGF-1 LR3: A modified IGF-1 analog that escapes binding proteins, so it stays active ≥24 h.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.